返回 Agenda
Learning from Novel Regulatory Approaches During the COVID Pandemic and Opportunities for the Future
Session Chair(s)
Beata Stepniewska, MPHARM
Deputy Director , Head of Regulatory Affairs
Medicines for Europe, Belgium
Christine Moore, PHD
Executive Director, Global External Advocacy and Standards
Organon & Co., United States
Learning from Novel Regulatory Approaches During the COVID Pandemic and Opportunities for the Future
Speaker(s)
The EU Experience in Managing COVID19 Crisis- What Worked Well; What We Could Have Done Differently
Agnes Mathieu-Mendes, RPH
European Health & Digital Executive Agency (HaDEA), Belgium
Head of Unit
The Lessons Learned from WHO Global Perspective
Deusdedit Mubangizi
WHO, Switzerland
Technical Officer, WHO Prequalification Program
Quality Lessons Learned
Alonza Cruse
FDA, United States
Director, Office of Pharmaceutical Quality Operations, ORA, OGROP
Outcome of the Industry Survey on Measures Put in Place in the EU During COVID19 Crisis
Virginia Acha, PHD, MSC
MSD, United States
Global Lead, Global Regulatory Policy
Panel Discussion - How to translate Key Lessons Learned from COVID-19 to the Future of Pharmaceutical Policy? - Moderated by:
Beata Stepniewska, MPHARM
Medicines for Europe, Belgium
Deputy Director , Head of Regulatory Affairs
Panelist
Evdokia Korakianiti, PHD, MSC
European Medicines Agency, Netherlands
Head of Quality and Safety of Medicines
Panelist
David Churchward, MS
Lonza Biologics, United Kingdom
Global Head Sterility Assurance, Cell and Gene Technologies